Status:
COMPLETED
Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics
Eligibility Criteria
Inclusion
- Scheduled for an ophthalmic surgical procedure
Exclusion
- Known allergy to bee venom
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00198549
Start Date
September 1 2004
End Date
March 1 2005
Last Update
March 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Eye Institute
Cincinnati, Ohio, United States, 45242